Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Lockheed Martin stock slides after Patriot missile deal, Goldman sticks to $430 sell target

Lockheed Martin stock slides after Patriot missile deal, Goldman sticks to $430 sell target

Lockheed Martin has struck a seven-year framework agreement with the U.S. Department of War to more than triple production capacity of its PAC-3 missile interceptors, a key part of the Patriot air-defense system. Output is expected to rise to about 2,000 a year from roughly 600 as demand for air defenses climbs, and the missiles have also been supplied to Ukraine. The U.S. military awarded Lockheed a record $9.8 billion contract in September for 1,970 Patriot missiles. Reuters
7 January 2026
··
Netflix stock steadies after Warner board rejects Paramount bid again, earnings next

Netflix stock steadies after Warner board rejects Paramount bid again, earnings next

Netflix shares were up 0.1% at $90.73 in after-hours trading on Wednesday after Warner Bros. Discovery told shareholders to reject Paramount Skydance’s amended tender offer and stick with Netflix’s merger agreement. “Paramount’s offer continues to provide insufficient value,” Warner chair Samuel A. Di Piazza Jr. said. Netflix traded between $90.09 and $92.41 in the regular session; Warner Bros. Discovery was up 0.3% and Paramount Skydance fell 1.1%. Warner Bros. Discovery
7 January 2026
····
JPMorgan set to take over Apple Card from Goldman in $20 billion switch

JPMorgan set to take over Apple Card from Goldman in $20 billion switch

JPMorgan Chase has struck a deal to take over Apple Inc.’s credit-card program from Goldman Sachs, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. JPMorgan would become the new issuer — the bank that extends the credit and runs the account — for Apple Card, one of the largest co-branded card programs in the United States with about $20 billion in balances, the report said. JPMorgan and Goldman declined to comment, and Apple did not immediately respond to a request for comment. Reuters
7 January 2026
··
Sandisk Corporation stock steadies after CES-fueled spike as Jan. 29 earnings loom

Sandisk Corporation stock steadies after CES-fueled spike as Jan. 29 earnings loom

Sandisk Corp shares were last up 1.2% at $353.56 in after-hours trading on Wednesday. Western Digital and Seagate slid 8.9% and 6.7%, but Sandisk held near the highs after a 27%+ jump on Tuesday tied to Nvidia CEO Jensen Huang’s CES remarks on a new layer of storage technology; it traded between $331.74 and $355.10 on Wednesday. Nvidia rose 1%, and “we’re going to have a very strong earnings season for Big Tech,” said Jed Ellerbroek at Argent Capital, pointing to higher capital spending. Reuters
7 January 2026
···
Strategy Inc stock rises after MSCI drops plan to kick bitcoin-treasury firms out of indexes

Strategy Inc stock rises after MSCI drops plan to kick bitcoin-treasury firms out of indexes

Strategy was up 2.5% at $161.83 in after-hours trading on Wednesday after MSCI scrapped a plan to exclude digital-asset treasury companies from its indexes. MSCI said it would keep its current approach — covering Strategy, which it lists as a firm whose digital-asset holdings are at least half of total assets — while it launches a broader review; Strategy said the policy would hold for MSCI’s February 2026 index review. Bitcoin fell 2.7% to $90,986, and Strategy’s shares were down about 47.5% last year. Reuters
7 January 2026
···
AbbVie circles Revolution Medicines in possible $20 billion-plus deal: WSJ, Bloomberg

AbbVie circles Revolution Medicines in possible $20 billion-plus deal: WSJ, Bloomberg

AbbVie is in advanced talks to buy cancer-drug developer Revolution Medicines, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. Revolution shares jumped nearly 30% after the report, while AbbVie rose more than 5%. https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-talks-buy-biotech-revolution-medicines-wsj-reports-2026-01-07/
7 January 2026
·
Why Lockheed Martin stock is sliding: Trump payout threat collides with PAC-3 missile ramp and a Goldman sell

Why Lockheed Martin stock is sliding: Trump payout threat collides with PAC-3 missile ramp and a Goldman sell

Lockheed Martin shares slid about 4.5% in afternoon trading on Wednesday after U.S. President Donald Trump said he would block dividends and share buybacks for defense contractors until they speed up weapons production. Trump also urged new production plants and called defense executive pay “exorbitant,” while offering no details on enforcement; Northrop Grumman, RTX and General Dynamics shares were also lower. Reuters
7 January 2026
······
1 … 558 559 560 561 562 … 893
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.